Now showing items 1-10 of 24
Organ damage mitigation with the Baskent Sickle Cell Medical Care Development Program (BASCARE)
The Eastern Mediterranean is among the regions where sickle cell disease (SCD) is common. The morbidity and mortality of this disease can be postponed to adulthood through therapies implemented in childhood. The present ...
Effect of Hereditary Hemochromatosis Gene H63D and C282Y Mutations on Iron Overload in Sickle Cell Disease Patients
Objective: Hemochromatosis is an autosomal recessive disease that is one of the most important reasons for iron overload. Sickle cell disease is a hemoglobinopathy that occurs as a result of a homozygous mutation in the ...
Significance of electronic health records: A comparative study of vaccination rates in patients with sickle cell disease
Objective: In this study, we investigated the influence of electronic health records (EHR) and electronic vaccination schedule applications on the vaccination status of patients who were admitted to our Center for the ...
Hematopoietic Stem Cell Transplantation in Adult Sickle Cell Disease: Problems and Solutions
Sickle cell disease-related organ injuries cannot be prevented despite hydroxyurea use, infection prophylaxis, and supportive therapies. As a consequence, disease-related mortality reaches 14% in adolescents and young ...
Development of Acute Promyelocytic Leukemia in a Patient With Gouty Arthritis on Long Term Colchicine
Colchicine is a frequently used drug in rheumatological diseases. Acute promyelocytic leukemia developed in a patient who used colchicine for gouty arthritis since 10 years is presented and the possible relation between ...
A rare hematological complication of visceral leishmaniasis: hemophagocytic syndrome
The term "hemophagocytosis" describes the pathologic finding of activated macrophages, engulfing erythrocytes, leukocytes, platelets and their precursor cells. This phenomenon is an important finding in patients with ...